-
1 Comment
Lansen Pharmaceutical Holdings Limited is currently in a long term uptrend where the price is trading 70.5% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.5.
Finally, its free cash flow fell by 37.4% to $3M since the same quarter in the previous year.
Based on the above factors, Lansen Pharmaceutical Holdings Limited gets an overall score of 2/5.
| Sector | |
|---|---|
| Industry | |
| Exchange | F |
| CurrencyCode | EUR |
| ISIN | None |
| Beta | 0.96 |
|---|---|
| Dividend Yield | 2.5% |
| Market Cap | 100M |
| PE Ratio | 122.0 |
| Target Price | None |
Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally. It operates through Pharmaceuticals, Cosmetics Products, and Healthcare Products segments. The company offers specialist medicines and Chinese medicine generic drugs; cosmetic products; and plant extracts and healthcare products. It also engages in research, development, and industrialization of industrial enzyme preparations, molecular biology tool enzymes, and bioactive factors for cosmetics and biological skincare products. The company was founded in 2001 and is headquartered in Ningbo, the People's Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1LP.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
